Crinetics Pharmaceuticals, Inc. Operating Lease, Liability, Current
Crinetics Pharmaceuticals, Inc. (CRNX) had Operating Lease, Liability, Current of $6.58 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-03
- 2026-06-30: Operating Lease, Liability, Current $6.58M.
- 2026-03-31: Operating Lease, Liability, Current $6.54M.
- 2025-12-31: Operating Lease, Liability, Current $6.49M.
- 2025-09-30: Operating Lease, Liability, Current $6.44M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $6.58M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $6.54M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $6.49M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $6.44M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $6.61M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $6.88M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $7.15M 10-K · filed 2026-02-26 |
| 2024-09-30 | $7.41M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $7.45M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $5.79M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $4.17M 10-K · filed 2025-02-27 |
| 2023-09-30 | $3.99M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $1.11M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $1.08M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.05M 10-K · filed 2024-02-28 |
| 2022-09-30 | $1.02M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $993.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $965.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $939.00K 10-Q · filed 2022-11-14 |
| 2021-03-31 | $860.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $835.00K 10-K · filed 2021-03-30 |
| 2020-09-30 | $810.00K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $782.00K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $753.00K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $724.00K 10-K · filed 2020-03-09 |
| 2019-09-30 | $696.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $678.00K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $665.00K 10-Q · filed 2019-05-13 |